International Consolidated Airlines Aktie
WKN DE: A1H6AJ / ISIN: ES0177542018
12.10.2022 16:30:30
|
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
NEW YORK and MAINZ, GERMANY, OCTOBER 12, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in
Weiter zum vollständigen Artikel bei "RSS Importer"
Weiter zum vollständigen Artikel bei "RSS Importer"

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu International Consolidated Airlines S.A.mehr Nachrichten
Analysen zu International Consolidated Airlines S.A.mehr Analysen
16.09.25 | International Consolidated Airlines Outperform | Bernstein Research | |
15.09.25 | International Consolidated Airlines Outperform | Bernstein Research | |
12.09.25 | International Consolidated Airlines Equal Weight | Barclays Capital | |
09.09.25 | International Consolidated Airlines Sell | UBS AG | |
20.08.25 | International Consolidated Airlines Outperform | Bernstein Research |
Aktien in diesem Artikel
BioNTech (ADRs) | 83,95 | 1,02% |
|
International Consolidated Airlines S.A. | 4,46 | 0,70% |
|
International Consolidated Airlines Group S.A. (spons. ADRs) | 10,34 | -0,29% |
|
Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs | 8 775,00 | -0,85% |
|
Pfizer Inc. | 20,29 | -0,39% |
|